Date and Time | Title | |
---|---|---|
May 11, 2021 9:30am - 10:00am (Eastern) | CDx Launch Success: From Early Biomarker Development to Commercialization An overview of opportunities associated with early biomarker investment for enhancing the demonstration of drug efficacies in target populations
| ![]() |
May 11, 2021 10:06am - 10:41am (Eastern) | Keynote - Facing Unknowns and Challenges: COVID-19 Testing in the Vaccine Era
| |
May 11, 2021 11:55am - 1:37pm (Eastern) | Integrating Personalized Medicine into Healthcare: Progress and a Path Forward During this session, experts in precision diagnostics, targeted therapy and healthcare delivery will discuss a first-of-its-kind landscape analysis applying a quantitative multi-factorial framework to assess the clinical adoption of personalized medicine in health care throughout the United States. Based on a survey of a representative sample of 153 health care providers, the analysis , which was commissioned by the Personalized Medicine Coalition, shows that 83 percent of the institutions studied scored a two or higher on the five-point scale used to examine their integration efforts. The study also showed that only 22 percent of the institutions studied scored a four or a five on the personalized medicine integration scale. Panelists will discuss this system-wide but incomplete push to implement personalized medicine in clinical settings, highlighting both the momentum that the field has as well as the limitations associated with the utilization of new precision medicine technologies and practices with extraordinary but understudied potential benefits. | ![]() |
May 11, 2021 1:40pm - 2:35pm (Eastern) | The Evolution of Precision Diagnostics in Advancing Oncology Treatment Strategies
| ![]() |